KCNN4 and cancer: In light of the data presented here and previous studies supporting the potential for drug delivery through stimulated endogenous transmembrane transport mechanisms, the possibility that KCa3.1 channel activation might provide an additional means of sensitizing cancer cells to cytotoxins is one worth exploring further.